TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05776836

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dermal filler
Description: Subjects will be consecutively included to receive FASY F in nasolabial folds and cheeks and FASY P in periorbital areas.
Study: NCT05240911

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levothyroxine Sodium Tablets
Description: For patients in experimental group, initial levothyroxine dose is calculated through the Poisson regression model; and for patients in comparator group, initial levothyroxine dose is calculated through 1.6 ug/kg/d.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levothyroxine Sodium Tablets
Description: For patients in experimental group, initial levothyroxine dose is calculated through the Poisson regression model; and for patients in comparator group, initial levothyroxine dose is calculated through 1.6 ug/kg/d.
Study: NCT05454371

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Colli-Pee UAS devices
Description: Colli-Pee UAS device variants will be evaluated during this study
Study: NCT05216042

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Study diet
Description: Participants will consume the study diet for 5 days provided by the clinical research unit's metabolic kitchen (at UAB)

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Study diet
Description: Participants will consume the study diet for 5 days provided by the clinical research unit's metabolic kitchen (at UAB)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise capacity VO2 max determination
Description: Each participant's maximal oxygen capacity will be determined using a modified Bruce treadmill protocol and will also undergo a DEXA scan to determine the body mass.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise capacity VO2 max determination
Description: Each participant's maximal oxygen capacity will be determined using a modified Bruce treadmill protocol and will also undergo a DEXA scan to determine the body mass.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Challenge
Description: Each participant will walk at 70 % of his/her VO2max for 20 minutes on treadmill and will also undergo a resting energy expenditure test.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Challenge
Description: Each participant will walk at 70 % of his/her VO2max for 20 minutes on treadmill and will also undergo a resting energy expenditure test.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose Challenge
Description: Participants will come in fasting state on day 6th and will be given 75 gm oral glucose solution to drink, followed by blood collection every hour for next 8 hours.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose Challenge
Description: Participants will come in fasting state on day 6th and will be given 75 gm oral glucose solution to drink, followed by blood collection every hour for next 8 hours.
Study: NCT05970198

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Total Marrow irradiation，TMI
Description: TMI radiation dose On the 5th day (-5 days) before transplantation, an irradiation dose of 8 Gy is given.~TMI uses a 6-18MV linear accelerator, the patient lies on his side in a single irradiation field, covered with a 1 cm thick plexiglass frame, and the radioactive source is 4 meters away from the body surface of the human side. The anterior and anterior positions were alternately irradiated, and the horizontal beam was irradiated in the opposite direction, and the actual irradiation dose was detected by the thermo-optical element of the 2570 roentgen dosimeter scale, and the irradiation dose of all parts of the body was adjusted to make the abdominal irradiation dose difference within 10%, the total dose was 8Gy, divided into 2 times a day, with an interval of 5 hours, and the dose rate was 4.99-6.96cGy/min.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Autologous hematopoietic stem cell transplantation
Description: Autologous hematopoietic stem cell transplantation;Porting method melphalan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation
Description: Autologous hematopoietic stem cell transplantation;Porting method melphalan
Study: NCT06548256

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miyarisan-BM (Clostridium Butyricum Miyairi)
Description: probiotics

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miyarisan-BM (Clostridium Butyricum Miyairi)
Description: probiotics
Study: NCT05373654

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: F-SUS Questionnaire
Description: This F-SUS questionnaire uses a Likert scale including 5 possible responses ranging from  I do not agree at all to  I completely agree  (Celenza A 2011, Croasmun JT 2011). The F-SUS is a short questionnaire with 10 questions (Brooke J 2013). In its original version half of the questions express strong agreement and the other half disagreement. Thus, all the even-numbered items (2, 4, 6, 8, 10) allow the participant to express a very negative opinion (disagreement). On the other hand, the odd-numbered items allow the participant to express a very positive opinion (strong agreement).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview (only for dissatisfied patients)
Description: Patients that are dissatisfied with the recharge procedure (Score F-SUS \< 70/100) will be invited to a so-called complementary information interview (an interview after the questionnaire has been completed).~The corpus (the study group that will be interviewed) will naturally be diverse men/women, patients who were improved or not by stimulation, implanted with a rechargeable stimulator directly/replacing a stimulator, different brands of stimulator... The patient must agree to the interview and the way it will be performed (signature of consent form). The interview may be face-to -face at the site or by remote videoconference depending on the wishes and availability of the patient. There is no payment for these interviews but travelling or videoconference expenses are reimbursed All interviews will be audio- taped for further qualitative analysis.
Study: NCT06054074

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Appreciation of Body Functionality Induction
Description: The positive induction takes place in a virtual environment of a dressing room and includes the following methods to induce positive appreciation of body functionality: 1) a narrative that aims to take the participants back to a time in the past when they held a higher positive body image. 2) A green virtual costume, representing their body at that time in the past and the positive attitude and feelings towards their body. 3) Five daily life tasks involving the use of the lower back, accompanied by auditory reminders and visual cues (green costume) to preserve the induction effect.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Negative Appreciation of Body Functionality Induction
Description: The negative induction takes place in a virtual environment of a dressing room and includes the following methods to induce a lower appreciation of body functionality: 1) a narrative that aims to take the participants back to a time in the past when they held a lower positive body image. 2) A red virtual costume, representing their body at that time in the past and the negative attitude and feelings towards their body. 3) Five daily life tasks involving the use of the lower back, accompanied by auditory reminders and visual cues (red costume) to preserve the induction effect.
Study: NCT05029635

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HMPL-523
Description: HMPL-523 will be oral administrated once daily for 24 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: HMPL-523 matching placebo will be oral administrated once daily for 24 weeks .
Study: NCT06152445

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Wheat bread
Description: Different wheat breads

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Wheat bread
Description: Different wheat breads

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wheat bread
Description: Different wheat breads

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wheat bread
Description: Different wheat breads

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wheat bread
Description: Different wheat breads
Study: NCT06272474

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CAD-CAM zirconia crowns using buccal interocclusal record.
Description: Virtual occlusal interferences adjustment of CAD-CAM zirconia crowns using buccal interocclusal record.~First, scanning the buccal interocclusal record for each patient with the two arches in maximum intercuspation position (MIP) will be performed. The IOS will immediately reproduce the occlusal state of the digital casts; this method is called the buccal bite registration method (BBR).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CAD-CAM zirconia crowns using lateral interocclusal records.
Description: Virtual occlusal interferences adjustment of CAD-CAM zirconia crowns using lateral interocclusal record.~A second scan will be performed for each patient to record lateral mandibular excursion. Then, three STL files will be exported; maxillary arch, mandibular arch at MIP and lateral mandibular excursion
Study: NCT05773794

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Soymilk, green tea, or blueberry
Description: One dose of soymilk, green tea, or blueberry blends (460mL) with breakfast.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: Breakfast with milk or water, without soymilk, green tea, or blueberry blends.
Study: NCT05415995

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Drug eluting Balloon
Description: Drug eluting Balloon is a kind of the product that has been used for many years. By filling the micropores on the surface of the balloon with anti-proliferative drugs like immunosuppressive agents, the balloon is expanded and contacted with the lesion to rapidly release the drug to the local arterial wall.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Drug eluting Balloon
Description: Drug eluting Balloon is a kind of the product that has been used for many years. By filling the micropores on the surface of the balloon with anti-proliferative drugs like immunosuppressive agents, the balloon is expanded and contacted with the lesion to rapidly release the drug to the local arterial wall.
Study: NCT04943575

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: EZC Pak
Description: After the onset of common cold symptoms, participants will take one pill (EZC Pak) each day for a period of 5 days.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: EZC Pak +D
Description: After the onset of common cold symptoms, participants will take one pill (EZC Pak +D) each day for a period of 5 days.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: After the onset of common cold symptoms, participants will take one pill (Placebo) each day for a period of 5 days.
Study: NCT05129059

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Logotherapy
Description: Logotherapy is a method of finding meaning with three basic principles. The first principle is that life is meaningful in every situation , even in the most desperate moments. The second principle is that the main source of motivation is the desire to find meaning in life. The third is that an individual is free to choose his own attitude even in the worst conditions.
Study: NCT04994951

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone Acetonide Acetate and Urea Cream.
Description: 10g/tube and CalcipotriolOintment,10g/tube are used alternately.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Qing-Re-Liang-Xue Decoction.
Description: One dose of granules is mixed, poured into 500ml of boiling water, and taken twice in the morning and afternoon. Women stop taking Chinese medicine during the first 3 days of menstruation.The period of treatment will be 10 weeks.
Study: NCT04158622

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PnR + laser/cryotherapy
Description: Pneumatic retinopexy plus laser/cryotherapy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PPV + laser/cryotherapy
Description: Pars plana vitrectomy plus laser/cryotherapy
Study: NCT06494631

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Xeltis Hemodialysis Access (aXess) graft
Description: The aXess graft is a sterile, restorative biodegradable polymer-based vascular graft, consisting of a tubular structure with a 6mm inner diameter. It is comprised of a highly porous polymer matrix and an embedded electropolished nitinol reinforcement layer (Strain Relief System). The aXess graft is able to support both straight and loop configurations and may be implanted in the upper arm and forearm.
Study: NCT05554419

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Given IV or SC

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone Marrow Aspiration and Biopsy
Description: Undergo bone marrow aspiration and biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration and Biopsy
Description: Undergo bone marrow aspiration and biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration and Biopsy
Description: Undergo bone marrow aspiration and biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration and Biopsy
Description: Undergo bone marrow aspiration and biopsy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cytarabine
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposome-encapsulated Daunorubicin-Cytarabine
Description: Given IV

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO
Study: NCT05254431

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Novel Moderate Intensity Interval Exercise~The Experimental Design is a randomized trial of moderate intensity interval training (5-minute intervals at 50% VO2peak 3 times weekly for 12 weeks) in Veterans with COPD and OSA compared with standard of care controls
Study: NCT06438978

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tuberculosis Vaccine
Description: 1. Live, attenuated Mycobacterium tuberculosis (M. tb)- MTBVAC (MTBVAC)01 strain~2. 3-17x105CFU (Per dose) Sucrose Sodium glutamate~3. Lyophilized pellet in vials (10doses)~4. 0.1 mL/dose (After reconstitution with 1 mL/vial sterilized water for injection)
Study: NCT06537960

Intervention type: PROCEDURE
Group type: OTHER
Intervention: 18FDG PET-CT
Description: 18FDG PET-CT will be performed in 2 phases:~1. st standard phase: Standard acquisition (vertex to mid-thigh) at 1 hour post-injection of radiotracer~2. nd phase: Complementary abdomino-pelvic acquisition at 2.5 hours post radiotracer injection.
Study: NCT05032612

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PBM Therapy
Description: After the endodontic treatment, PBM therapy will be performed using a 660 nm diode laser (SiroLaser Advance Plus, Dentsply Sirona Inc, Charlotte, NC, USA), with an 8mm tip diameter.The laser tip will be placed on the following external surfaces in a contact mode: mesiobuccal, distobuccal, mesiolingual and distolingual . The power output of the laser will be 50mW and will be verified by Power Meter (PM600 Power/Energy meter, Molectron Detector Inc, Portland, OR, USA). Each site will be irradiated for 25 s with an energy density of 10 J/cm2 .

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: PBM Sham
Description: For the PBM sham similar procedure as PBM therapy will be performed without activating the laser.
Study: NCT05086536

Intervention type: OTHER
Intervention: no intervention
Description: This is a retrospective and observational study.
Study: NCT06033742

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10374 tablets
Description: Single or multiple dosing of HS-10374 orally in a fasting state

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: HS-10374-matched placebo tablets
Description: Single or multiple dosing of HS-10374-matched placebo orally in a fasting state
Study: NCT06296186

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure Therapy
Description: Exposure therapy for PTSD

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Prolonged Exposure Therapy
Description: Exposure therapy for PTSD
Study: NCT05437003

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NeuraLight software-based platform
Description: NeuraLight is an investigational software-based platform that is used for assessment and evaluation of neurological conditions including PD patients

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NeuraLight software-based platform
Description: NeuraLight is an investigational software-based platform that is used for assessment and evaluation of neurological conditions including PD patients
Study: NCT05515250

Intervention type: DEVICE
Group type: OTHER
Intervention: Use of neurostimulation device
Description: In humans, abdominal pain is modulated by the vagus nerve. Stimulation of the vagus nerve has been suggested to reduce visceral sensitivity and abdominal pain. IB-stim is the Percutaneous Electrical Nerve Field Stimulation (PENS) device. It is a non-invasive, outpatient therapy. PENFS has been shown to be efficacious in pediatric patients with abdominal pain.
Study: NCT06490016

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: web based education
Description: The web page will be prepared with professional support in line with the guidelines of the Web Content Accessibility Guide (WCAG / WIEK 2.1) developed by W3C.~1. st meeting: online Informed Consent will be obtained. After the meeting, the Personal Information Form, Menstrual Attitude Scale, Menstrual Symptom Scale, State and Trait Anxiety Scale will be filled out online.~2. nd interview: Module 1-2.~3. rd interview: Module 3 -4.~4. th meeting: Module 5.They will be asked to fill out the System Usability Scale.~5. th interview: During the first menstrual period after the training, the Menstrual Attitude Scale, Menstrual Symptom Scale, and State Anxiety Scale will be completed online.~6. th interview: During the second menstrual period after the training, the Menstrual Attitude Scale, Menstrual Symptom Scale, and State Anxiety Scale will be completed online.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Face to face
Description: In face-to-face training, female internal reproductive organ models, female external reproductive organ models, training content prepared with Braille alphabet, menstrual hygiene management kit (underwear, pads, napkins, calendar) materials will be used. Pictures and audio descriptions will be used in web-based training.~1. st interview: Informed Consent . After the meeting, the Personal Information Form, Menstrual Attitude Scale, Menstrual Symptom Scale, State and Trait Anxiety Scale will be filled out.~2. nd meeting: Module 1-2~3. rd meeting: Module 3- 4~4. th meeting: Module 5.~5. th interview: Menstrual Attitude Scale, Menstrual Symptom Scale, State Anxiety Scale will be completed.~6. th interview: Menstrual Attitude Scale, Menstrual Symptom Scale, State Anxiety Scale will be completed.
Study: NCT04914689

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Internal focus of attention feedback
Description: Participants will complete 12 sessions over a 3-week period of functional movement retraining while receiving mirror feedback. Participants will be instructed to perform each functional task in a manner that keeps their knee in line with their toes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual internal focus of attention feedback
Description: Participants will complete 12 sessions over a 3-week period of functional movement retraining while receiving visual feedback via laser. Participants will be instructed to perform each functional task in a manner that does causes the laser to move up and down but not side-to-side.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auditory external focus of attention feedback
Description: Participants will complete 12 sessions over a 3-week period of functional movement retraining while receiving auditory feedback. Participants will be instructed to perform each functional task in a manner that does not cause the auditory tool to elicit a noise.
Study: NCT05115838

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Islatravir
Description: ISL 47, 52, or 57 mg implantable rod placed subdermally on the upper arm.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Islatravir
Description: ISL 47, 52, or 57 mg implantable rod placed subdermally on the upper arm.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Islatravir
Description: ISL 47, 52, or 57 mg implantable rod placed subdermally on the upper arm.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo implantable rod placed subdermally on the upper arm.
Study: NCT03458221

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole Oral Product
Description: Letrozole 2.5mg tablet - 2.5mg once dailty until progression of disease.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bicalutamide Oral Product
Description: Bicalutatmide 150mg tablet - 150mg once daily until progression of disease.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus Oral Product
Description: Everolimus 10mg tablet - 10mg once daily until progression of disease.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole Oral Product
Description: Itraconazole 100mg capsule - 300mg twice daily until progression of disease.